» Articles » PMID: 29392130

Is Able to Induce Apoptotic Cell Death of Pterygium-Derived Human Keratinocytes

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2018 Feb 3
PMID 29392130
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Pterygium is a relatively common eye disease that can display an aggressive clinical behaviour. To evaluate the effects of on human pterygium-derived keratinocytes, specimens of pterygium from 20 patients undergoing pterygium surgical excision were collected. Pterygium explants were put into culture and derived keratinocytes were treated with an alcoholic extract of 1.3% in 0.001% Benzalkonium Chloride for 3, 6, and 24 h. Cultured cells were examined for CAM5.2 (anti-cytokeratin antibody) and CD140 (anti-fibroblast transmembrane glycoprotein antibody) expression between 3th and 16th passage to assess cell homogeneity. TUNEL technique and Annexin-V/PI staining in flow cytometry were used to detect keratinocyte apoptosis. We showed that exerts a proapoptotic effect on pterygium-derived keratinocytes already after 3 h treatment. Moreover, after 24 h treatment, induces a significant increase in TUNEL as well as Annexin-V/PI positive cells in comparison to untreated samples. Our study confirms previous observations highlighting the expression, in pterygium keratinocytes, of nuclear VEGF and gives evidence for the first time to the expression of nuclear and cytoplasmic VEGF-R1. All in all, these findings suggest that could have some therapeutic potential in the treatment and prevention of human pterygium.

Citing Articles

Evaluation of the clinical efficacy of modified LSC transplantation plus BCL implantation in the treatment of pterygium.

Li Y, Meng L, Gong L, Wang X, Yang X, Li T BMC Ophthalmol. 2024; 24(1):521.

PMID: 39627768 PMC: 11613735. DOI: 10.1186/s12886-024-03785-z.


Development and Characterization of Curcumin-Silver Nanoparticles as a Promising Formulation to Test on Human Pterygium-Derived Keratinocytes.

Stati G, Rossi F, Trakoolwilaiwan T, Tung L, Mourdikoudis S, Thanh N Molecules. 2022; 27(1).

PMID: 35011514 PMC: 8746426. DOI: 10.3390/molecules27010282.


Phytochemical Profile and Antioxidant and Antiproliferative Activity of on Pterygium Fibroblasts.

Lopez-Montemayor P, Zavala J, Montalvo-Parra M, Guerrero-Ramirez G, Mayolo-Deloisa K, Enriquez-Ochoa D Evid Based Complement Alternat Med. 2021; 2021:5814221.

PMID: 34707671 PMC: 8545536. DOI: 10.1155/2021/5814221.

References
1.
Ghosh S, Banerjee S, Sil P . The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food Chem Toxicol. 2015; 83:111-24. DOI: 10.1016/j.fct.2015.05.022. View

2.
Cui Y, Li H, Gao Z, Liang N, Ma S, Meng F . Regulation of Apoptosis by miR-122 in Pterygium via Targeting Bcl-w. Invest Ophthalmol Vis Sci. 2016; 57(8):3723-30. DOI: 10.1167/iovs.16-19402. View

3.
Bradley J, Yang W, Bradley R, Reid T, Schwab I . The science of pterygia. Br J Ophthalmol. 2009; 94(7):815-20. DOI: 10.1136/bjo.2008.151852. View

4.
Chainani-Wu N . Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med. 2003; 9(1):161-8. DOI: 10.1089/107555303321223035. View

5.
Lee D, Cho H, Kim J, Choi J, Joo C . Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea. 2001; 20(7):738-42. DOI: 10.1097/00003226-200110000-00013. View